Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |